Prospective comparison of PSMA PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previously negative biopsy: Preliminary data from PROSPET-BX trial

MLA

E. Lopci, et al. “Prospective Comparison of PSMA PET/CT vs. MpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: Preliminary Data from PROSPET-BX Trial.” European Urology, vol. 83, Feb. 2023, pp. S1393–94. EBSCOhost, https://doi.org/10.1016/s0302-2838(23)01013-8.

APA

E. Lopci, M. Lazzeri, L. Disconzi, D. Maffei, V. Fasulo, P.P. Avolio, M. Paciotti, L. Pasini, A. Benetti, R.F. Hurle, A.R. Saita, P.G. Colombo, K. Marzo, L. Leonardi, L. Balzarini, A. Chiti, G.F. Guazzoni, P. Casale, N.M. Buffi, & G. Lughezzani. (2023). Prospective comparison of PSMA PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previously negative biopsy: Preliminary data from PROSPET-BX trial. European Urology, 83, S1393–S1394. https://doi.org/10.1016/s0302-2838(23)01013-8

Chicago

E. Lopci, M. Lazzeri, L. Disconzi, D. Maffei, V. Fasulo, P.P. Avolio, M. Paciotti, et al. 2023. “Prospective Comparison of PSMA PET/CT vs. MpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: Preliminary Data from PROSPET-BX Trial.” European Urology 83 (February): S1393–94. doi:10.1016/s0302-2838(23)01013-8.